Q3 2025 Lifeward Ltd Earnings Call Transcript
Key Points
- Lifeward Ltd (LFWD) achieved a record quarter for ReWalk placements for Medicare beneficiaries, marking the second consecutive record since CMS established their fee schedule in April 2024.
- The company implemented operational efficiencies, resulting in a 16% reduction in quarterly cash burn and a 27% reduction in non-GAAP operating loss compared to the previous year.
- Lifeward Ltd expanded patient access by receiving its first Medicare Advantage commercial revenue for the ReWalk 7 personal exoskeleton.
- The company expanded its market access to Europe with CE mark approval, which represents approximately 40% of its global addressable exoskeleton opportunity.
- Lifeward Ltd completed a $3 million loan with Oroed, enhancing its near-term liquidity and supporting the ongoing execution of its transformation plan.
- Revenue growth was modest, with a year-over-year increase of only 1.1%, from $6.1 million in Q3 2024 to $6.2 million in Q3 2025.
- Revenue from 3G products and services decreased from $3.6 million in Q3 2024 to $3.1 million in Q3 2025, primarily due to timing factors and quarterly revenue mix.
- GAAP operating expenses increased to $5.9 million in Q3 2025 from $5.4 million in Q3 2024, driven by a $2 million earnout write-down recognized in the prior year quarter.
- The company ended Q3 2025 with only $2 million in cash and cash equivalents, raising concerns about its liquidity position.
- Lifeward Ltd faces challenges in scaling operations and maintaining focus on core businesses, as highlighted by the need for strategic partnerships and channel management improvements.
Good morning and welcome to the 3rd quarter 2025 Lifeward Earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing, then 0 on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad. To withdraw your question, please press 2.
Please note this event is being recorded. I would now like to turn the conference over to Almag Adar, CFO of Lifeword. Please go ahead.
Thank you, operator, and thanks to everyone who has joined us on the call today. My name is Elmo Gab. I'm Lifeor's Chief Financial Officer, and with me on today's call is our President and Chief Executive Officer, Mark Grant. Earlier this morning, Lifeor issued a press release detailing the financial results for the third quarter, which ended September 30, 2025.
I would like to ask you to review the full text of our forward-looking
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
